Package 51662-1663-2

{"route": ["INTRAMUSCULAR"], "spl_id": "23fdb616-0c61-44fe-e063-6394a90ad8f1", "openfda": {"nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "unii": ["YKH834O4BH"], "rxcui": ["1870205"], "spl_set_id": ["23fdb616-0c60-44fe-e063-6394a90ad8f1"], "pharm_class_cs": ["Catecholamines [CS]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 DOSE PACK in 1 CARTON (51662-1663-2)  / .3 mL in 1 DOSE PACK (51662-1663-1)", "package_ndc": "51662-1663-2", "marketing_start_date": "20121115"}], "brand_name": "AUVI-Q", "product_id": "51662-1663_23fdb616-0c61-44fe-e063-6394a90ad8f1", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Catecholamine [EPC]", "Catecholamines [CS]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1663", "generic_name": "AUVI-Q", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AUVI-Q", "active_ingredients": [{"name": "EPINEPHRINE", "strength": ".3 mg/.3mL"}], "application_number": "NDA201739", "marketing_category": "NDA", "marketing_start_date": "20121115", "listing_expiration_date": "20261231"}